Olympian Caster Semenya cleared to compete as a woman without taking testosterone-reducing drugs

Caster Semenya
Image: AAP/Darren England

Runner Caster Semenya will be allowed to compete without having to take testosterone-reducing medication after a Swiss court ordered the International Association of Athletics Federations to suspend implementation of new regulations while Semenya’s appeal is pending.

The court ruled that the two-time Olympic 800-meter champion, the dominant force in women’s middle distance running, is clear to race in events of all distances, according to a news release.

Semenya reacted with a Tweet saying “Born a winner,” and an image with the quote: “Be the change that you wish to see in the world.”

Last month the IAAF — athletics’ governing body — adopted a controversial policy which required athletes with a difference in sex development (DSD) to take medication to reduce their blood testosterone levels, if they wanted to compete internationally at middle-distance events.


“I am thankful to the Swiss judges for this decision,” Semenya, who is hyperandrogenous — meaning she has elevated levels of testosterone — said in a statement.

Related article:  Government-issued proof-of-vaccination cards are on the way

Athletics’ governing body believes DSD athletes have a competitive advantage — findings that were disputed by Semenya and her legal team.

Read full, original post: Caster Semenya: Olympic champion cleared to compete

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend